Peter Haviernik Selected Research

Matrix Metalloproteinase Inhibitors

9/2008

Hematopoiesis in mice is extremely resilient to wide variation in TIMP/MMP balance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Haviernik Research Topics

Disease

2	Neoplasms (Cancer) 09/2008 - 03/2003
1	Tuberculosis (Tuberculoses) 06/2020
1	Thrombocytopenia (Thrombopenia) 02/2009
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2006
1	Multiple Sclerosis 01/2006
1	Myeloid Leukemia (Leukemia, Myelocytic) 12/2004
1	Leukemia 03/2003
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2003

Drug/Important Bio-Agent (IBA)

1	InterferonsIBA 06/2020
1	Mitogen-Activated Protein KinasesIBA 02/2009
1	Janus KinasesIBA 02/2009
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2009
1	Matrix Metalloproteinase InhibitorsIBA 09/2008
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2006
1	Myelin Basic ProteinIBA 01/2006
1	Tissue Inhibitor of Metalloproteinase-1IBA 12/2004
1	Messenger RNA (mRNA)IBA 03/2003
1	Proteins (Proteins, Gene)FDA Link 03/2003
1	CytokinesIBA 03/2003
1	Cyclin-Dependent Kinase Inhibitor p16IBA 03/2003

Therapy/Procedure

2	Therapeutics 09/2008 - 01/2006
1	Transplantation 01/2006